Our approach
We acknowledge that deciding for a drug delivery system is an important and long term decision, requiring both scientific and commercial evaluations. We prefer to be involved in the dialogue at the very early point in the process of selecting delivery system. We can, together with our network, perform feasibility tests of the combination device/formulation. We will be able to supply high numbers of devices for your clinical trials. Welcoming new opportunities
Direct-Haler A/S has a flexible outlook on the development of the companys business, and in how our technology can be fully exploited and commercialized. We are looking for business partnerships both concerning commercialization (route to market) and for accessing complementary technology to the DirectHaler™ technologies. We invite you to take contact to Dr. Troels Keldmann, for a dialogue on opportunities for collaboration. | 
